Rational engineering of a functional CpG-free ITR for AAV gene therapy
X Pan, Y Yue, M Boftsi, LP Wasala, NT Tran, K Zhang… - Gene therapy, 2022 - nature.com
Inverted terminal repeats (ITRs) are the only wild-type components retained in the genome
of adeno-associated virus (AAV) vectors. To determine whether ITR modification is a viable …
of adeno-associated virus (AAV) vectors. To determine whether ITR modification is a viable …
Novel application of trimethyl chitosan as an adjuvant in vaccine delivery
The application of natural carbohydrate polysaccharides for antigen delivery and its
adjuvanation potential has garnered interest in the scientific community in the recent years …
adjuvanation potential has garnered interest in the scientific community in the recent years …
Innovative strategies for co-delivering antigens and CpG oligonucleotides
Y Krishnamachari, AK Salem - Advanced drug delivery reviews, 2009 - Elsevier
Cytosine–phosphorothioate–guanine oligodeoxynucleotides (CpG ODN) is a recent class of
immunostimulatory adjuvants that includes unmethylated CpG dinucleotide sequences …
immunostimulatory adjuvants that includes unmethylated CpG dinucleotide sequences …
CpG DNA and LPS induce distinct patterns of activation in human monocytes
G Hartmann, AM Krieg - Gene therapy, 1999 - nature.com
A specific set of immune functions is switched on in response to DNA containing
unmethylated CpG dinucleotides in particular base contexts ('CpG motifs'). Plasmids, viral …
unmethylated CpG dinucleotides in particular base contexts ('CpG motifs'). Plasmids, viral …
Silica nanoparticle as a lymph node targeting platform for vaccine delivery
Nanoparticles have emerged as the platform of choice to improve the efficacy and safety of
subunit vaccines. A major challenge underlying the use of nanomaterials in vaccines lies in …
subunit vaccines. A major challenge underlying the use of nanomaterials in vaccines lies in …
Toll-like receptor 9, CpG DNA and innate immunity
AA Ashkar, KL Rosenthal - Current molecular medicine, 2002 - ingentaconnect.com
Innate immunity provides the first line of defense against invading pathogens and is
essential for survival in the absence of adaptive immune responses. Innate immune …
essential for survival in the absence of adaptive immune responses. Innate immune …
The promise of nucleic acid vaccines
NP Restifo, H Ying, L Hwang, WW Leitner - Gene therapy, 2000 - nature.com
Establishing the effective use of 'naked'nucleic acids as vaccines would undoubtedly be one
of the most important advances in the history of vaccinology. While nucleic acids show much …
of the most important advances in the history of vaccinology. While nucleic acids show much …
Mechanisms and applications of immune stimulatory CpG oligodeoxynucleotides
AM Krieg - Biochimica et Biophysica Acta (BBA)-Gene Structure …, 1999 - Elsevier
Immune stimulation has been widely recognized as an undesirable side effect of certain
antisense oligodeoxynucleotides (ODN) which can interfere with their therapeutic …
antisense oligodeoxynucleotides (ODN) which can interfere with their therapeutic …
Methods for enhancing antibody-induced cell lysis and treating cancer
G Weiner, G Hartmann - US Patent 7,534,772, 2009 - Google Patents
US7534772B2 - Methods for enhancing antibody-induced cell lysis and treating cancer -
Google Patents US7534772B2 - Methods for enhancing antibody-induced cell lysis and …
Google Patents US7534772B2 - Methods for enhancing antibody-induced cell lysis and …
Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12-and IFN-γ-dependent mechanisms
PS Walker, T Scharton-Kersten… - Proceedings of the …, 1999 - National Acad Sciences
Resistance to murine leishmaniasis correlates with development of a CD4+ T helper 1 (Th1)-
predominant immune response. To determine whether immunostimulatory CpG-containing …
predominant immune response. To determine whether immunostimulatory CpG-containing …